GPR55: The Third Cannabinoid Receptor?

6/21/2018

A scientific study published last year was the latest to focus the research community on the potential of the GPR55 receptor, which is now known to be the third identified receptor in the human endocannabinoid system. The study found a role for the receptor in the use of CBD to treat Dravet syndrome, a rare and severe form of epilepsy.

The research team from the University of Washington at Seattle noted that they saw potential to “extend the scope of CBD treatment to autistic-like behaviors, and provide initial mechanistic insights into CBD’s therapeutic actions,” according to the abstract in the Proceedings of the National Academy of Sciences (PNAS).

Click Here to Read the Full Article

Source : https://cannabisnow.com/gpr55-the-third-cannabinoid-receptor/
Powered By GrowthZone